Acquisition of high-risk human papillomavirus infection in a population-based cohort of danish women

Sexually Transmitted Diseases

Volumn 36, Issue 10, 2009, Pages 609-615

  Nielsen, Ann ^a   Iftner, Thomas ^b   Munk, Christian ^a   Kjaer, Susanne K ^a,c  

^a INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

^b Sektion Experimentelle Virologie   (Germany)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ORAL CONTRACEPTIVE AGENT;

ADULT; AGE DISTRIBUTION; AGING; ALCOHOL CONSUMPTION; ARTICLE; CHLAMYDIASIS; CIGARETTE SMOKING; COHORT ANALYSIS; CONDOM; CONDYLOMA ACUMINATUM; DENMARK; FEMALE; FOLLOW UP; GYNECOLOGICAL EXAMINATION; HIGH RISK POPULATION; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN PAPILLOMAVIRUS TYPE 33; HUMAN PAPILLOMAVIRUS TYPE 35; HUMAN PAPILLOMAVIRUS TYPE 39; HUMAN PAPILLOMAVIRUS TYPE 45; HUMAN PAPILLOMAVIRUS TYPE 51; HUMAN PAPILLOMAVIRUS TYPE 52; HUMAN PAPILLOMAVIRUS TYPE 53; HUMAN PAPILLOMAVIRUS TYPE 56; HUMAN PAPILLOMAVIRUS TYPE 58; HUMAN PAPILLOMAVIRUS TYPE 59; HUMAN PAPILLOMAVIRUS TYPE 66; HUMAN PAPILLOMAVIRUS TYPE 68; INCIDENCE; INFECTION RISK; INTERVIEW; MAJOR CLINICAL STUDY; ORAL CONTRACEPTION; POPULATION RESEARCH; SEXUAL BEHAVIOR; SEXUAL INTERCOURSE; SIDE EFFECT; TREATMENT DURATION; VIRUS INFECTION; WART VIRUS;

ADULT; COHORT STUDIES; DENMARK; FEMALE; HUMANS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 70350513109     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/OLQ.0b013e3181a96d0e     Document Type: Article

References (29)

1. Munoz N, Castellsague X, de Gonzalez AB, et al. Chapter 1: HPV in the etiology of human cancer. Vaccine 2006; 24(suppl 3):S1-S10.
2. Munoz N, Bosch FX, de Sanjose S, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003; 348:518-527. (Pubitemid 36159887)
3. Moscicki AB, Hills N, Shiboski S, et al. Risks for incident human papillomavirus infection and low-grade squamous intraepithelial lesion development in young females. JAMA 2001; 285:2995-3002.
4. Ho GY, Bierman R, Beardsley L, et al. Natural history of cervi-covaginal papillomavirus infection in young women. N Engl J Med 1998; 338:423-428.
5. Winer RL, Lee SK, Hughes JP, et al. Genital human papilloma-virus infection: incidence and risk factors in a cohort of female university students. Am J Epidemiol 2003; 157:218-226.
6. Giuliano AR, Harris R, Sedjo RL, et al. Incidence, prevalence, and clearance of type-specific human papillomavirus infections: The Young Women?s Health Study. J Infect Dis 2002; 186:462-469.
7. Munoz N, Mendez F, Posso H, et al. Incidence, duration, and determinants of cervical human papillomavirus infection in a cohort of Colombian women with normal cytological results. J Infect Dis 2004; 190:2077-2087.
8. Syrjanen S, Shabalova I, Petrovichev N, et al. Acquisition of high-risk human papillomavirus infections and pap smear abnormalities among women in the New Independent States of the Former Soviet Union. J Clin Microbiol 2004; 42:505-511.
9. Sellors JW, Karwalajtys TL, Kaczorowski J, et al. Incidence, clearance and predictors of human papillomavirus infection in women. CMAJ 2003; 168:421-425.
10. Rousseau MC, Abrahamowicz M, Villa LL, et al. Predictors of cervical coinfection with multiple human papillomavirus types. Cancer Epidemiol Biomarkers Prev 2003; 12:1029-1037.
11. Rousseau MC, Villa LL, Costa MC, et al. Occurrence of cervical infection with multiple human papillomavirus types is associated with age and cytologic abnormalities. Sex Transm Dis 2003; 30:581-587.
12. Thomas KK, Hughes JP, Kuypers JM, et al. Concurrent and sequential acquisition of different genital human papillomavirus types. J Infect Dis 2000; 182:1097-1102.
13. Kjaer SK, van den Brule AJ, Bock JE, et al. Human papilloma-virus-the most significant risk determinant of cervical intraepi-thelial neoplasia. Int J Cancer 1996; 65:601-606.
14. Kjaer SK, Hogdall E, Frederiksen K, et al. The absolute risk of cervical abnormalities in high-risk human papillomavirus-posi-tive, cytologically normal women over a 10-year period. Cancer Res 2006; 66:10630-10636.
15. Iftner T, Villa LL. Chapter 12: Human papillomavirus technologies. J Natl Cancer Inst Monogr 2003; 31:80-88.
16. Klug SJ, Molijn A, Schopp B, et al. Comparison of the performance of different HPV genotyping methods for detecting genital HPV types. J Med Virol 2008; 80:1264-1274.
17. Syrjanen S, Shabalova I, Petrovichev N, et al. Age-specific incidence and clearance of high-risk human papillomavirus infections in women in the former Soviet Union. Int J STD AIDS 2005; 16:217-223.
18. Franco EL, Villa LL, Sobrinho JP, et al. Epidemiology of acquisition and clearance of cervical human papillomavirus infection in women from a high-risk area for cervical cancer. J Infect Dis 1999; 180:1415-1423.
19. Woodman CB, Collins S, Winter H, et al. Natural history of cervical human papillomavirus infection in young women: A longitudinal cohort study. Lancet 2001; 357:1831-1836.
20. Richardson H, Kelsall G, Tellier P, et al. The natural history of type-specific human papillomavirus infections in female university students. Cancer Epidemiol Biomarkers Prev 2003; 12:485-490.
21. Rousseau MC, Pereira JS, Prado JC, et al. Cervical coinfection with human papillomavirus (HPV) types as a predictor of acquisition and persistence of HPV infection. J Infect Dis 2001; 184: 1508-1517.
22. Kjaer SK, Munk C, Winther JF, et al. Acquisition and persistence of human papillomavirus infection in younger men: A prospective follow-up study among Danish soldiers. Cancer Epidemiol Biomarkers Prev 2005; 14:1528-1533.
23. Schiffman M, Castle PE, Jeronimo J, et al. Human papillomavirus and cervical cancer. Lancet 2007; 370:890-907.
24. Liaw KL, Hildesheim A, Burk RD, et al. A prospective study of human papillomavirus (HPV) type 16 DNA detection by poly-merase chain reaction and its association with acquisition and persistence of other HPV types. J Infect Dis 2001; 183:8-15.
25. Green J, Berrington de GA, Smith JS, et al. Human papilloma-virus infection and use of oral contraceptives. Br J Cancer 2003; 88:1713-1720.
26. Stubenrauch F, Iftner T. Molecular basis of cervical neoplasia. In: Jordan JA, Singer A, eds. The Cervix. Oxford, Victoria: Black-well publishing Massachusetts, 2006:277.
27. Burchell AN, Winer RL, de Sanjose S, et al. Chapter 6: Epidemiology and transmission dynamics of genital HPV infection. Vaccine 2006; 24:52-61.
28. Manhart LE, Koutsky LA. Do condoms prevent genital HPV infection, external genital warts, or cervical neoplasia? A meta-analysis. Sex Transm Dis 2002; 29:725-735.
29. Winer RL, Hughes JP, Feng Q, et al. Condom use and the risk of genital human papillomavirus infection in young women. N Engl J Med 2006; 354:2645-2654.